Data61, Commonwealth Scientific and Industrial Research Organisation, Hobart, Tasmania, Australia.
Neuroscience Research Australia, Randwick Sydney, New South Wales, Australia.
J Clin Sleep Med. 2022 Mar 1;18(3):861-870. doi: 10.5664/jcsm.9742.
Oral appliance (OA) therapy is a well-tolerated alternative to continuous positive airway pressure. However, it is less efficacious. A major unresolved clinical challenge is the inability to accurately predict who will respond to OA therapy. We recently developed a model to estimate obstructive sleep apnea pathophysiological endotypes. This study aimed to apply this physiological-based model to predict OA treatment responses.
Sixty-two men and women with obstructive sleep apnea (aged 29-71 years) were studied to investigate the efficacy of a novel OA device. An in-laboratory diagnostic followed by an OA treatment efficacy polysomnography were performed. Seven polysomnography variables from the diagnostic study plus age and body mass index were included in our machine-learning-based model to predict OA therapy response according to standard apnea-hypopnea index (AHI) definitions. Initially, the model was trained on data from the first 45 participants using 10-fold cross-validation. A blinded independent validation was then performed for the remaining 17 participants.
Mean accuracy of the trained model to predict OA therapy responders vs nonresponders (AHI < 5 events/h) using 10-fold cross-validation was 91% ± 8%. In the independent blinded validation, 100% (AHI < 5 events/h); 59% (AHI < 10 events/h); 71% (50% reduction in AHI); and 82% (50% reduction in AHI to < 20 events/h) of the 17 participants were correctly classified for each of the treatment outcome definitions respectively.
While further evaluation in larger clinical data sets is required, these findings highlight the potential to use routinely collected sleep study and clinical data with machine learning-based approaches underpinned by obstructive sleep apnea endotype concepts to help predict treatment outcomes to OA therapy for people with obstructive sleep apnea.
Dutta R, Tong BK, Eckert DJ. Development of a physiological-based model that uses standard polysomnography and clinical data to predict oral appliance treatment outcomes in obstructive sleep apnea. . 2022;18(3):861-870.
口腔矫治器(OA)治疗是一种耐受性良好的持续气道正压通气替代方法。然而,其疗效较低。一个尚未解决的主要临床挑战是无法准确预测谁会对 OA 治疗有反应。我们最近开发了一种模型来估计阻塞性睡眠呼吸暂停的病理生理内型。本研究旨在应用这种基于生理学的模型来预测 OA 治疗反应。
对 62 名患有阻塞性睡眠呼吸暂停的男性和女性(年龄 29-71 岁)进行研究,以调查一种新型 OA 设备的疗效。进行了一项实验室诊断,随后进行了一项 OA 治疗效果多导睡眠图检查。我们的基于机器学习的模型纳入了诊断研究中的 7 项多导睡眠图变量,外加年龄和体重指数,根据标准的呼吸暂停低通气指数(AHI)定义来预测 OA 治疗反应。最初,使用 10 倍交叉验证对前 45 名参与者的数据进行模型训练。然后对其余 17 名参与者进行了盲法独立验证。
使用 10 倍交叉验证,训练后的模型预测 OA 治疗应答者(AHI<5 次/小时)的平均准确率为 91%±8%。在独立的盲法验证中,17 名参与者中的 100%(AHI<5 次/小时);59%(AHI<10 次/小时);71%(AHI 降低 50%);82%(AHI 降低 50%至<20 次/小时)的治疗结果定义分别得到正确分类。
虽然还需要在更大的临床数据集进行进一步评估,但这些发现突出了使用基于机器学习的方法以及基于阻塞性睡眠呼吸暂停内型概念的常规收集睡眠研究和临床数据来帮助预测阻塞性睡眠呼吸暂停患者对 OA 治疗的反应的潜力。
Dutta R, Tong BK, Eckert DJ. 开发一种基于生理学的模型,该模型使用标准多导睡眠图和临床数据预测口腔矫治器治疗阻塞性睡眠呼吸暂停的效果。睡眠呼吸医学杂志。2022;18(3):861-870.